Formulated medicine for treatment and prevention of opportunisti

Details Formulated medicine for treatment and prevention of opportunisti Formulated medicine for treatment and prevention of opportunisti

1993-03-02

1996-11-19

Sayala, Chhaya D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530394, 530395, 530400, A61K 3840

Patent

active

055762999

ABSTRACT:
The protein lactoferrin can be used both for treating and/or preventing of portunistic infections frequently complicating Immunodeficiency Virus positive animals including human beings. The protein greatly improves the quality of life in such immunodeficiency virus infected animals. The dosage of the protein is usually 0.1-100 mg/kg daily, and preferably 0.5-50 mg/kg.

REFERENCES:
patent: 4977137 (1990-12-01), Nichols et al.
patent: 5093115 (1992-03-01), Stevenson et al.
patent: 5158979 (1992-10-01), Clarkson, Jr. et al.
patent: 5198419 (1993-03-01), Ando et al.
Weinberg Physiological Reviews, vol. 64, No. 1 Jan. 1984, pp. 65-102.
Kurth, Intervivology, vol. 31(6), pp. 301-314, 1990.
Tyms et al., J. Antimicrob. Chemother., vol. 23 Suppl A, pp. 89-105, 1989.
Prufer-Kramer et al., Fortschr. Med., vol. 109(7) pp. 169-172, 1991.
Weijmer et al. Lancet (1990), vol. 336, pp. 464-466.

Affiliated with

Also associated with

Rating

Formulated medicine for treatment and prevention of opportunisti does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Formulated medicine for treatment and prevention of opportunisti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulated medicine for treatment and prevention of opportunisti will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-541070